Asahi Life Asset Management CO. LTD. Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Asahi Life Asset Management CO. LTD. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 690 shares of the medical equipment provider’s stock, valued at approximately $360,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $31,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $36,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $573.15 on Friday. The company’s fifty day moving average price is $569.87 and its 200 day moving average price is $529.06. The stock has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,077 shares of company stock worth $4,620,025. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.